newsfilter
← Latest News
PR Newswire·

Kuehn Law Encourages Investors of Rhythm Pharmaceuticals, Inc. to Contact Law Firm

  • Kuehn Law, PLLC is investigating Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) officers & directors for potential fiduciary duty breaches & self-dealing.
  • Shareholders may be eligible for damages & corporate governance reforms.
  • Long-term RYTM stockholders can contact Sophia Anne Silayan at [email protected] or (833) 672-0814 for a free consultation.
  • Kuehn Law covers all case costs & charges no fees to investor clients.
  • Shareholders are urged to contact the firm immediately due to potential time limits on enforcing rights.
  • The announcement highlights the importance of shareholder participation in maintaining financial market integrity.
  • Additional information is available on the Kuehn Law website regarding shareholder derivative litigation.